UP

Axar.Az Logo

AZ RU EN آذ فا
Polish security neutralizes drone over government buildings
Azerbaijan, Uzbekistan FMs discuss strategic cooperation
Arab, Islamic countries back Qatar over Israeli strike

WHO has stopped testing these drugs

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The World Health Organization (WHO) has stopped testing hydroxychloroxine (an anti-malarial drug) and lopinavir / ritonavir (an antiretroviral drug) in hospitalized patients with a coronavirus diagnosis.

Axar.az informs that, preliminary test results showed that hydroxychloroxine and lopinavi / ritonavir did not, or almost did not, reduce mortality among hospitalized patients with COVID-19.
Date
2020.07.05 / 09:53
Author
Nurlana Ahmadova
Share
See also

Scientists develop a drug that trains the immune system

Early smoking increases cancer risk up to 4 times

Chikungunya fever is spreading rapidly in South China

Harmanci: COVID-19 still present, caution needed

Millions at risk as US ends AIDS funding - UNAIDS report

Smart hydrogel developed to heal chronic wounds faster

WHO pushes bold reforms, launching 3 by 35 initiative

Scientists discover new coronavirus

Azerbaijan performs first deceased donor organ transplants

Fifty countries affected by USAID freeze - WHO

Latest
TERMS OF USEAll rights reserved. When using a material link is required. When using the material on the internet pages of the corresponding transition is required.

COMMUNICATION WITH US Baku city, Binagadi district, street S.S.Akhundov
(+994 12) 464-61-74, 464-61-75, 464-61-76
[email protected]
For reklam: [email protected]

www.axar.az - 2025
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla